Phase 1/2 Clinical Trial of Interferon ??2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

2007 ◽  
Vol 30 (6) ◽  
pp. 655-662 ◽  
Author(s):  
Stephen A. Boorjian ◽  
Matthew I. Milowsky ◽  
Jodi Kaplan ◽  
Martin Albert ◽  
Marta Vallee Cobham ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Advanced Renal Cell Carcinoma ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid

Phase I trial of interferon ?2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma

Cancer ◽  
2002 ◽  
Vol 95 (6) ◽  
pp. 1220-1227 ◽  
Author(s):  
Jonathan S. Goldberg ◽  
Manuel Vargas ◽  
Alyssa S. Rosmarin ◽  
Matthew I. Milowsky ◽  
Nicholas Papanicoloau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Phase I ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Advanced Renal Cell Carcinoma ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid

Phase II Study of Interferon-?? and All-Trans Retinoic Acid in Metastatic Renal Cell Carcinoma

1998 ◽  
Vol 21 (1) ◽  
pp. 62-64 ◽  
Author(s):  
Bernard Escudier ◽  
Alain Ravaud, ◽  
Dominique Berton ◽  
Christine Chevreau ◽  
Jean-Yves Douillard ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma

2011 ◽  
Vol 18 (0) ◽  
Author(s):  
Sebastien J. Hotte ◽  
G.A. Bjarnason ◽  
D.Y.C. Heng ◽  
M.A.S. Jewett ◽  
A. Kapoor ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Progression Free Survival ◽  
Advanced Renal Cell Carcinoma ◽  
Free Survival ◽  
Clinical Trial Endpoint ◽  
Trial Endpoint

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma

2020 ◽  
Vol 38 (5) ◽  
pp. 1383-1389
Author(s):  
Ana M. Molina ◽  
Johannes C. van der Mijn ◽  
Paul Christos ◽  
John Wright ◽  
Charlene Thomas ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Phase I ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Advanced Renal Cell Carcinoma

Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma

Oncology ◽  
2002 ◽  
Vol 63 (2) ◽  
pp. 130-138 ◽  
Author(s):  
C. Bacoyiannis ◽  
M.A. Dimopoulos ◽  
H.P. Kalofonos ◽  
C. Nicolaides ◽  
G. Aravantinos ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Cell Carcinoma ◽  
Interferon Gamma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

2006 ◽  
Vol 175 (1) ◽  
pp. 57-62 ◽  
Author(s):  
I. Bleumer ◽  
E. Oosterwijk ◽  
J.C. Oosterwijk-Wakka ◽  
M.C.W. Völler ◽  
S. Melchior ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Renal Cell Carcinoma ◽  
Monoclonal Antibody ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Interleukin 2 ◽  
Advanced Renal Cell Carcinoma ◽  
Chimeric Monoclonal Antibody
Sign in / Sign up

Export Citation Format

Share Document